Follow-up surveillance among colorectal cancer survivors of different sexual orientations.
Cancer survivorship
Colorectal neoplasms
Quality of care
Sexual and gender minorities
Surveillance
Journal
Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
07
11
2020
accepted:
30
03
2021
pubmed:
15
4
2021
medline:
5
4
2022
entrez:
14
4
2021
Statut:
ppublish
Résumé
The purpose of this study was to examine receipt of follow-up surveillance among sexual minority and heterosexual survivors and identify survivor-, physician-, and practice-level characteristics associated with follow-up surveillance. An average of 3 years after their stage I-III colorectal cancer diagnosis, we recruited survivors from four cancer registries. A questionnaire, which queried about sexual orientation and other eligibility criteria, was mailed to all cancer survivors. Subsequently, 418 eligible survivors without recurrent disease participated in a telephone survey. Colorectal cancer-specific follow-up surveillance was defined as colonoscopy, carcinoembryonic antigen (CEA) test, or imaging test. We used logistic regression with forward selection to obtain models that best explained each follow-up test. About 10% of survivors received no follow-up surveillance, while 70% had colonoscopies. While survivors irrespective of sexual orientation received follow-up surveillance, sexual minority survivors had 3 times the odds of receiving imaging tests compared to heterosexual survivors. Having a designated provider of any specialty was most salient for the receipt of surveillance. Sexual minority survivors' greater receipt of imaging tests may indicate providers perceive them at greater risk for recurrence than heterosexual survivors. Future studies need to examine provider behaviors towards monitoring colorectal cancer survivors of diverse sexual orientations. Guidelines recommend surveillance of colorectal cancer survivors to improve survival. This study showed that having a designated provider for follow-up is most salient for the receipt of surveillance, most survivors receive surveillance, and sexual minority survivors had more imaging tests compared to heterosexual survivors.
Identifiants
pubmed: 33851339
doi: 10.1007/s11764-021-01039-1
pii: 10.1007/s11764-021-01039-1
pmc: PMC8531882
mid: NIHMS1743986
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
445-454Subventions
Organisme : NCI NIH HHS
ID : R01 CA181392
Pays : United States
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64. https://doi.org/10.3322/caac.21601 .
doi: 10.3322/caac.21601
Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–70. https://doi.org/10.1200/jco.2013.50.7442 .
doi: 10.1200/jco.2013.50.7442
pubmed: 24220554
El-Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt-Chapman ML, et al. American Cancer Society Colorectal Cancer Survivorship Care Guidelines. CA Cancer J Clin. 2015;65(6):428–55. https://doi.org/10.3322/caac.21286 .
doi: 10.3322/caac.21286
pubmed: 26348643
pmcid: 5385892
Steele SR, Chang GJ, Hendren S, Weiser M, Irani J, Buie WD, et al. Practice guideline for the surveillance of patients after curative treatment of colon and rectal cancer. Dis Colon Rectum. 2015;58(8):713–25. https://doi.org/10.1097/dcr.0000000000000410 .
doi: 10.1097/dcr.0000000000000410
pubmed: 26163950
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Colon Cancer. Version 4.2018. 2018.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Rectal Cancer. Version 3.2018. 2018.
Zhao Y, Yi C, Zhang Y, Fang F, Faramand A. Intensive follow-up strategies after radical surgery for nonmetastatic colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2019;14(7):e0220533. https://doi.org/10.1371/journal.pone.0220533 .
doi: 10.1371/journal.pone.0220533
pubmed: 31361784
pmcid: 6667274
Sehdev A, Sherer EA, Hui SL, Wu J, Haggstrom DA. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities. Cancer. 2017;123(12):2338–51. https://doi.org/10.1002/cncr.30569 .
doi: 10.1002/cncr.30569
pubmed: 28211937
Paulson EC, Veenstra CM, Vachani A, Ciunci CA, Epstein AJ. Trends in surveillance for resected colorectal cancer, 2001-2009. Cancer. 2015;121(19):3525–33. https://doi.org/10.1002/cncr.29469 .
doi: 10.1002/cncr.29469
pubmed: 26079928
McDougall JA, Banegas MP, Wiggins CL, Chiu VK, Rajput A, Kinney AY. Rural disparities in treatment-related financial hardship and adherence to surveillance colonoscopy in diverse colorectal cancer survivors. Cancer Epidemiol Biomark Prev. 2018;27(11):1275–82. https://doi.org/10.1158/1055-9965.Epi-17-1083 .
doi: 10.1158/1055-9965.Epi-17-1083
Hines RB, Jiban MJH, Lee E, Odahowski CL, Wallace AS, Adams SJE, et al. Characteristics associated with nonreceipt of surveillance testing and the relationship with survival in stage II and III colon cancer. Am J Epidemiol. 2020;190:239–50. https://doi.org/10.1093/aje/kwaa195 .
doi: 10.1093/aje/kwaa195
Brawarsky P, Neville BA, Fitzmaurice GM, Earle C, Haas JS. Surveillance after resection for colorectal cancer. Cancer. 2013;119(6):1235–42. https://doi.org/10.1002/cncr.27852 .
doi: 10.1002/cncr.27852
pubmed: 23184361
Fish J, Williamson I. Exploring lesbian, gay and bisexual patients’ accounts of their experiences of cancer care in the UK. Eur J Cancer Care. 2018;27(1):e12501. https://doi.org/10.1111/ecc.12501 .
doi: 10.1111/ecc.12501
Fish J, Williamson I, Brown J. Disclosure in lesbian, gay and bisexual cancer care: towards a salutogenic healthcare environment. BMC Cancer. 2019;19(1):678. https://doi.org/10.1186/s12885-019-5895-7 .
doi: 10.1186/s12885-019-5895-7
pubmed: 31291940
pmcid: 6617610
Lisy K, Peters MDJ, Schofield P, Jefford M. Experiences and unmet needs of lesbian, gay, and bisexual people with cancer care: a systematic review and meta-synthesis. Psycho-Oncology. 2018;27(6):1480–9. https://doi.org/10.1002/pon.4674 .
doi: 10.1002/pon.4674
pubmed: 29462496
Kamen CS, Smith-Stoner M, Heckler CE, Flannery M, Margolies L. Social support, self-rated health, and lesbian, gay, bisexual, and transgender identity disclosure to cancer care providers. Oncol Nurs Forum. 2015;42(1):44–51. https://doi.org/10.1188/15.onf.44-51 .
doi: 10.1188/15.onf.44-51
pubmed: 25542320
pmcid: 4360905
Brown MT, McElroy JA. Unmet support needs of sexual and gender minority breast cancer survivors. Support Care Cancer. 2018;26(4):1189–96. https://doi.org/10.1007/s00520-017-3941-z .
doi: 10.1007/s00520-017-3941-z
pubmed: 29080921
Jabson JM, Kamen CS. Sexual minority cancer survivors' satisfaction with care. J Psychosoc Oncol. 2016;34(1-2):28–38. https://doi.org/10.1080/07347332.2015.1118717 .
doi: 10.1080/07347332.2015.1118717
pubmed: 26577277
Kamen CS, Alpert A, Margolies L, Griggs JJ, Darbes L, Smith-Stoner M, et al. "Treat us with dignity": a qualitative study of the experiences and recommendations of lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer. Support Care Cancer. 2019;27(7):2525–32. https://doi.org/10.1007/s00520-018-4535-0 .
doi: 10.1007/s00520-018-4535-0
pubmed: 30411237
Boehmer U, Clark MA, Ozonoff A, Winter M, Potter J. Survivors’ perceptions of quality of colorectal cancer care by sexual orientation. Am J Clin Oncol. 2020;43(9):660–6. https://doi.org/10.1097/coc.0000000000000732 .
doi: 10.1097/coc.0000000000000732
pubmed: 32889837
pmcid: 8011297
Boehmer U, Miao X, Ozonoff A. Health behaviors of cancer survivors of different sexual orientations. Cancer Causes Control. 2012;23(9):1489–96. https://doi.org/10.1007/s10552-012-0023-x .
doi: 10.1007/s10552-012-0023-x
pubmed: 22752329
Boehmer U, Gereige J, Winter M, Ozonoff A. Cancer survivors’ access to care and quality of life: do sexual minorities fare worse than heterosexuals? Cancer. 2019;125(9):3079–85.
doi: 10.1002/cncr.32151
Ford ME, Sterba KR, Armeson K, Malek AM, Knight KD, Zapka J. Factors influencing adherence to recommended colorectal cancer surveillance: experiences and behaviors of colorectal cancer survivors. J Cancer Educ. 2019;34(5):938–49. https://doi.org/10.1007/s13187-018-1398-5 .
doi: 10.1007/s13187-018-1398-5
pubmed: 30073494
pmcid: 6359985
Carpentier MY, Vernon SW, Bartholomew LK, Murphy CC, Bluethmann SM. Receipt of recommended surveillance among colorectal cancer survivors: a systematic review. J Cancer Surviv. 2013;7(3):464–83. https://doi.org/10.1007/s11764-013-0290-x .
doi: 10.1007/s11764-013-0290-x
pubmed: 23677524
pmcid: 3737369
Chrischilles EA, McDowell BD, Rubenstein L, Charlton M, Pendergast J, Juarez GY, et al. Survivorship care planning and its influence on long-term patient-reported outcomes among colorectal and lung cancer survivors: the CanCORS disease-free survivor follow-up study. J Cancer Surviv. 2015;9(2):269–78. https://doi.org/10.1007/s11764-014-0406-y .
doi: 10.1007/s11764-014-0406-y
pubmed: 25354481
Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care. 2005;43(6):607–15.
doi: 10.1097/01.mlr.0000163658.65008.ec
Feldman JM, Waterman PD, Coull BA, Krieger N. Spatial social polarisation: using the Index of Concentration at the Extremes jointly for income and race/ethnicity to analyse risk of hypertension. J Epidemiol Community Health. 2015;69(12):1199–207. https://doi.org/10.1136/jech-2015-205728 .
doi: 10.1136/jech-2015-205728
pubmed: 26136082
Krieger N, Waterman PD, Spasojevic J, Li W, Maduro G, Van Wye G. Public health monitoring of privilege and deprivation with the Index of Concentration at the Extremes. Am J Public Health. 2016;106(2):256–63. https://doi.org/10.2105/ajph.2015.302955 .
doi: 10.2105/ajph.2015.302955
pubmed: 26691119
pmcid: 4815605
Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT. A short scale for measuring loneliness in large surveys: results from Two population-based studies. Res Aging. 2004;26(6):655–72. https://doi.org/10.1177/0164027504268574 .
doi: 10.1177/0164027504268574
pubmed: 18504506
pmcid: 2394670
Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705–14.
doi: 10.1016/0277-9536(91)90150-B
Kelley DE, Kent EE, Litzelman K, Mollica MA, Rowland JH. Dyadic associations between perceived social support and cancer patient and caregiver health: an actor-partner interdependence modeling approach. Psycho-oncology. 2019;28:1453–60. https://doi.org/10.1002/pon.5096 .
doi: 10.1002/pon.5096
pubmed: 30993811
pmcid: 6749989
Stuber J, Galea S, Ahern J, Blaney S, Fuller C. The association between multiple domains of discrimination and self-assessed health: a multilevel analysis of Latinos and blacks in four low-income New York City neighborhoods. Health Serv Res. 2003;38(6p2):1735–60.
doi: 10.1111/j.1475-6773.2003.00200.x
Carver C. You want to measure coping but your protocol's too long: consider the Brief COPE. Int J Behav Med. 1997;4(1):92–100.
doi: 10.1207/s15327558ijbm0401_6
Wagnild GM, Young HM. Development and psychometric evaluation of the Resilience Scale. J Nurs Meas. 1993;1(2):165–78.
pubmed: 7850498
Ayanian JZ, Zaslavsky AM, Arora NK, Kahn KL, Malin JL, Ganz PA, et al. Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2010;28(27):4154–61. https://doi.org/10.1200/jco.2009.27.3268 .
doi: 10.1200/jco.2009.27.3268
pubmed: 20713876
pmcid: 2953972
Martinez KA, Snyder CF, Malin JL, Dy SM. Patient-reported quality of care and pain severity in cancer. Palliat Support Care. 2015;13(4):875–84. https://doi.org/10.1017/s1478951514000777 .
doi: 10.1017/s1478951514000777
pubmed: 24967597
Sabatino SA, Thompson TD, Smith JL, Rowland JH, Forsythe LP, Pollack L, et al. Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv. 2013;7(1):32–43. https://doi.org/10.1007/s11764-012-0242-x .
doi: 10.1007/s11764-012-0242-x
pubmed: 23179495
Kupfer SS, Lubner S, Coronel E, Pickhardt PJ, Tipping M, Graffy P, et al. Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated comprehensive cancer centers. Cancer Med. 2018;7(11):5351–8. https://doi.org/10.1002/cam4.1678 .
doi: 10.1002/cam4.1678
pubmed: 30338661
pmcid: 6247039
Balasubramanian BA, Jetelina KK, Bowen M, Santini NO, Lee SC. Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States. Int J Care Coord. 2018;21(1-2):26–35. https://doi.org/10.1177/2053434518764634 .
doi: 10.1177/2053434518764634
pubmed: 30364563
pmcid: 6197490
Kamen C, Blosnich JR, Lytle M, Janelsins MC, Peppone LJ, Mustian KM. Cigarette smoking disparities among sexual minority cancer survivors. Prev Med Rep. 2015;2:283–6. https://doi.org/10.1016/j.pmedr.2015.04.004 .
doi: 10.1016/j.pmedr.2015.04.004
pubmed: 25984441
pmcid: 4430723
Jacobsen PB, DeRosa AP, Henderson TO, Mayer DK, Moskowitz CS, Paskett ED, et al. Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery. J Clin Oncol. 2018;36(20):2088–100. https://doi.org/10.1200/jco.2018.77.7482 .
doi: 10.1200/jco.2018.77.7482
pubmed: 29775389
pmcid: 6036622
Salz T, Baxi S. Moving survivorship care plans forward: focus on care coordination. Cancer Med. 2016;5(7):1717–22. https://doi.org/10.1002/cam4.733 .
doi: 10.1002/cam4.733
pubmed: 27075650
pmcid: 4944899
Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol. 2011;29(10):1280–9. https://doi.org/10.1200/jco.2010.32.1554 .
doi: 10.1200/jco.2010.32.1554
pubmed: 21357781
pmcid: 3083996
Kenzik KM. Health care use during cancer survivorship: review of 5 years of evidence. Cancer. 2019;125(5):673–80. https://doi.org/10.1002/cncr.31852 .
doi: 10.1002/cncr.31852
pubmed: 30561774
Vargas GM, Sheffield KM, Parmar AD, Han Y, Brown KM, Riall TS. Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer. Surgery. 2013;154(2):244–55. https://doi.org/10.1016/j.surg.2013.04.013 .
doi: 10.1016/j.surg.2013.04.013
pubmed: 23889952
Hawkins NA, Berkowitz Z, Rodriguez J, Miller JW, Sabatino SA, Pollack LA. Examining adherence with recommendations for follow-up in the prevention among colorectal cancer survivors study. Oncol Nurs Forum. 2015;42(3):233–40. https://doi.org/10.1188/15.Onf.233-240 .
doi: 10.1188/15.Onf.233-240
pubmed: 25901375
pmcid: 4501017
Gomez SL, Shariff-Marco S, DeRouen M, Keegan TH, Yen IH, Mujahid M, et al. The impact of neighborhood social and built environment factors across the cancer continuum: current research, methodological considerations, and future directions. Cancer. 2015;121(14):2314–30. https://doi.org/10.1002/cncr.29345 .
doi: 10.1002/cncr.29345
pubmed: 25847484
Gorey KM, Luginaah IN, Bartfay E, Fung KY, Holowaty EJ, Wright FC, et al. Effects of socioeconomic status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California, 1996-2006. Am J Public Health. 2011;101(1):112–9. https://doi.org/10.2105/ajph.2009.173112 .
doi: 10.2105/ajph.2009.173112
pubmed: 20299655
pmcid: 3000730
Gorey KM, Luginaah IN, Holowaty EJ, Zou G, Hamm C, Bartfay E, et al. Effects of being uninsured or underinsured and living in extremely poor neighborhoods on colon cancer care and survival in California: historical cohort analysis, 1996-2011. BMC Public Health. 2012;12:897. https://doi.org/10.1186/1471-2458-12-897 .
doi: 10.1186/1471-2458-12-897
pubmed: 23092403
pmcid: 3507906